期刊文献+

醛固酮诱导大鼠肾脏衰老机制研究 被引量:4

Mechanism of aldosterone induced rat kdney senescence
原文传递
导出
摘要 目的观察醛固酮是否诱导肾脏衰老。方法将大鼠右肾切除后随机分为4组:对照组(n=10)、模型组(n=8)、依普利酮组(100 mg.kg-1.d-1;n=8)及肼苯哒嗪组(80 mg.L-1,饮用;n=10);除对照组外,其余各组分别泵入醛固酮(0.75μg.h-1),观察5周后肾脏衰老改变。结果醛固酮可诱导5周龄的大鼠肾组织衰老标记物β-gal、p53和p21表达升高,SIRT1基因表达下降,伴高血压及蛋白尿、N-乙酰基-β-D氨基葡萄糖苷酶(NAG)的排泄率增加,这些变化可以被依普利酮阻断,但是肼苯哒嗪影响不大。结论醛固酮诱导肾小管上皮细胞损伤和衰老是通过醛固酮受体和p21依赖的途径。 Objective To investigate whether aldosterone induces cell senescence in the kidney. Methods Rats were randomly separated to vehicle (n = 10) ; aldosterone (0. 75 ug. h-1; n =8) ; aldosterone + eplerenone (100 mg . kg-1. d-1 ; n = 8) ; aldosterone + hydralazine (80 mg . L-1 in drinking water; n = 10). Results Aldosterone induced rats for 5 weeks exhibited by increased expression of senescence - associated β - galactosidase, p53 and cyclin - dependent kinase inhibitor ( p21 ) , and decreased expression of SIRT1. While, rats also showed hypertension and increased urinary excretion rates of proteins and N - acetyl -β- D- glucosaminidase by aldosterone infusion. These changes were abolished by eplerenone, a mineralocorticoid receptor (MR) antagonist, but unaffected by hydralazine (80 mg/liter in drinking water). Conclusion These findings indicate that aldosterone induces renal senescence in proximal tubular cells via the MR and p21 -dependent pathway, which may be involved in aldosterone-induced renal injury.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第1期42-44,共3页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金主任基金资助项目(81141040)
关键词 肾脏衰老 细胞周期调控基因p21和p53 沉默调节因子1(SIRT1) 醛固酮 renal senescence cyclin- dependent kinase inhibitor 1A(p21) tumor protein P53 Sirtuin 1 aldosterone
  • 相关文献

参考文献10

  • 1Nishiyama A,Yao L,Nagai Y. Possible contributions ot reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats[J].Hypertension,2004.841-848.
  • 2Williams GH,Burgess E,Kolloch RE. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension[J].American Journal of Cardiology,2004.990-996.
  • 3Westhoff JH,Hilgers KF,Steinbach MP. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a[J].Hypertension,2008.123-129.
  • 4Nishiyama A,Yoshizumi M,Hitomi H. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats[J].Journal of the American Society of Nephrology,2004.306-315.
  • 5Minamino T,Miyauchi H,Yoshida T. Endothelial cell senescence in human atherosclerosis:role of telomere in endothelial dysfunction[J].Circulation,2002.1541-1544.
  • 6Dimri GP,Lee X,Basile G. A biomarker that identifies senescent human cells in culture and in aging skin in vivo[J].Proceedings of the National Academy of Sciences(USA),1995,(20):9363-9367.
  • 7Krishnamurthy J,Torrice C,Ramsey MR. Ink4a/Arf expression is a biomarker of aging[J].Journal of Clinical Investigation,2004.1299-1307.
  • 8Min LJ,Mogi M,Li JM. Aldosterone and angiotensin Ⅱ synergistically induce mitogenic response in vascular smooth muscle cells[J].Circulation Research,2005.434-442.
  • 9Zhang XP,Liu F,Cheng Z. Cell fate decision mediated by p53 pulses[J].Proceedings of the National Academy of Sciences(USA),2009.12245-12250.
  • 10Henschkowski J,Stuck AE,Frey BM. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2(11beta-HSD2)activity in hypertensive patients[J].American Journal of Hypertension,2008.644-649.

同被引文献34

  • 1祝慧凤,万东,张芬.地黄梓醇脑保护的药理作用及机制研究进展[J].中国中药杂志,2009,34(23):2983-2986. 被引量:23
  • 2罗燕燕,张绍青,索建政,孙东豫,崔晓聪.高效液相色谱法测定地黄中梓醇的含量[J].中国药学杂志,1994,29(1):38-39. 被引量:39
  • 3Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, et al. Kidney allograft stone after kidney transplantation and its association with graft survival [ J ]. Int J Organ Transplant Med, 2015, 6 (3): 114-118.
  • 4Asher J, Vasdev N, Wyrley-Birch H, et al. A prospective randomised paired trial of sirolimus versus tacrolimus as primary immunosuppression following non- heart beating donor kidney transplantation [ J ]. Curr Urol, 2014, 7 (4): 174-180.
  • 5Te Riet L, van Esch JH, Roks AJ, et al. Hypertension: renin-angiotensin-aldosterone system alterations [ J ]. Circ Res, 2015, 116 (6): 960-975.
  • 6Singh P, Feld RI, Colombe BW, et al. Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts [ J ]. Clin Transplant, 2014, 28 (12): 1424-1432.
  • 7Daniel C, Vogelbacher R, Stief A, et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-[5 activation, inflammation and angiogenesis inchronic allograft nephropathy[J]. PLoS One, 2013, 8 (12): e83846.
  • 8Sandhu JS, Kansal S, Bajwa GS, et al. Ocular changes in renal allograft recipients and patients of chronic kidney disease[ J ]. Saudi J Kidney Dis Transpl, 2014, 25 (6) : 1285-1289.
  • 9Vaidya A, Underwood PC, Hopkins PN, et al. Abnormal aldosterone physiology and cardiometabolic risk factors [J]. Hypertension, 2013, 61 (4): 886-893.
  • 10Bollag WB. Regulation of aldosterone synthesis and secretion[J]. Compr Physiol, 2014, 4 (3) : 1017- 1055.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部